1. Home
  2. SMSI vs JSPR Comparison

SMSI vs JSPR Comparison

Compare SMSI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Micro Software Inc.

SMSI

Smith Micro Software Inc.

HOLD

Current Price

$2.68

Market Cap

14.0M

Sector

Technology

ML Signal

HOLD

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.58

Market Cap

14.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMSI
JSPR
Founded
1982
2018
Country
United States
United States
Employees
N/A
22
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0M
14.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SMSI
JSPR
Price
$2.68
$0.58
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$15.50
AVG Volume (30 Days)
132.7K
476.1K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
62.94
N/A
EPS
N/A
N/A
Revenue
$17,363,000.00
N/A
Revenue This Year
$13.97
N/A
Revenue Next Year
$53.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.32
52 Week High
$6.13
$3.53

Technical Indicators

Market Signals
Indicator
SMSI
JSPR
Relative Strength Index (RSI) 52.35 57.29
Support Level $2.51 $0.42
Resistance Level $6.13 $1.02
Average True Range (ATR) 0.14 0.08
MACD -0.10 0.03
Stochastic Oscillator 19.23 79.17

Price Performance

Historical Comparison
SMSI
JSPR

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: